Company Filing History:
Years Active: 2018-2020
Title: Innovations of Jiehao Chen in Cancer Treatment
Introduction
Jiehao Chen is a notable inventor based in Carmel, IN, who has made significant contributions to the field of cancer treatment through his innovative research. With a total of two patents to his name, Chen's work focuses on developing novel compounds that have the potential to improve therapeutic outcomes for various types of cancer.
Latest Patents
Chen's latest patents include the invention of 1-tetrahydropyranylcarbonyl-2,3-dihydro-1H-indole compounds specifically designed for treating cancer. This invention relates to certain novel 2,3-dihydro-1H-indole compounds, pharmaceutical compositions comprising these compounds, and methods of using them to treat a wide range of cancers. The cancers targeted by these compounds include melanoma, acute myeloid leukemia, chronic lymphocytic leukemia, colorectal cancer, breast cancer, lung cancer, ovarian cancer, fallopian tube carcinoma, primary peritoneal carcinoma, cervical cancer, gastric cancer, liver cancer, pancreatic cancer, thyroid cancer, glioblastoma, non-Hodgkin's lymphoma, and Hodgkin's lymphoma.
Career Highlights
Jiehao Chen is currently employed at Eli Lilly and Company, where he continues to advance his research in oncology. His work at this prestigious pharmaceutical company allows him to collaborate with other experts in the field and contribute to the development of effective cancer therapies.
Collaborations
Some of Chen's coworkers include Jolie Anne Bastian and Jeffrey Daniel Cohen, who are also involved in innovative research and development within the pharmaceutical industry.
Conclusion
Jiehao Chen's contributions to cancer treatment through his patented inventions highlight the importance of innovation in the medical field. His work not only showcases his expertise but also reflects the collaborative efforts within Eli Lilly and Company to combat cancer effectively.